Nanomaterials functionalized acidic ionic organosilica as highly active catalyst in the selective synthesis of benzimidazole via dehydrogenative coupling of diamines and alcohols

An acidic tungstate-based zwitterionic organosilica drived simple self-condensation of tungstic acid and zwitterionic organosilane (PMO-IL-WO42-), was remarkably demonstrated to be highly efficient and environmentally friendly catalyst for directly selective synthesis of benzimidazoles from benzyl alcohols under atmpshpheric air pressure and without any additional oxidant. The one-pot synthesis of benzimidazoles from benzyl alcohols and 1,2-phenylenediamine was efficiently achieved via direct dehydrogenative reaction using a low amount of recoverable PMO-IL-WO42- nanocatalyst in water under ambient conditions with a conversion efficiency of more than 90%. Enhancements in yield and selectivity of benzimidazole formation were observed when water was utilized as the solvent. Furthermore, the PMO-IL-WO42- nanocatalyst exhibited exceptional stability, demonstrating the ability to be effortlessly separated and reused for at least eight reaction cycles without any noticeable loss in activity or product selectivity. This method supports an eco-friendly atom economy and provides a sustainable approach to accessing benzimidazoles directly from benzyl alcohols under mild conditions, demonstrating its potential for practical applications in organic synthesis.

Recent achievements in the synthesis of benzimidazole derivatives

Benzimidazoles are a class of heterocyclic compounds in which a benzene ring is fused to the 4 and 5 positions of an imidazole ring. Benzimidazole refers to the parent compound, while benzimidazoles are a class of heterocyclic compounds having similar ring structures, but different substituents. Benzimidazole derivatives possess a wide range of bioactivities including antimicrobial, anthelmintic, antiviral, anticancer, and antihypertensive activities. Many compounds possessing a benzimidazole skeleton have been employed as drugs in the market. The application of benzimidazoles in other fields has also been documented. The synthesis of benzimidazole derivatives has attracted much attention from chemists and numerous articles on the synthesis of this class of heterocyclic compound have been reported over the years. The condensation between 1,2-benzenediamine and aldehydes has received intensive interest, while many novel methods have been developed. In this article, we will give a comprehensive review of studies on the synthesis of benzimidazole, which date back to 2013. We have also tried to describe reaction mechanisms as much as we can. The work might be useful for chemists who work in the synthesis of heterocycles or drug chemistry.

Bioactivity-Guided Synthesis: In Silico and In Vitro Studies of β-Glucosidase Inhibitors to Cope with Hepatic Cytotoxicity

The major cause of hyperglycemia can generally be attributed to β-glucosidase as per its involvement in non-alcoholic fatty liver disease. This clinical condition leads to liver carcinoma (HepG2 cancer). The phthalimides and phthalamic acid classes possess inhibitory potential against glucosidase, forming the basis for designing new phthalimide and phthalamic acid analogs to test their ability as potent inhibitors of β-glucosidase. The study also covers in silico (molecular docking and MD simulations) and in vitro (β-glucosidase and HepG2 cancer cell line assays) analyses. The phthalimide and phthalamic acid derivatives were synthesized, followed by spectroscopic characterization. The mechanistic complexities associated with β-glucosidase inhibition were identified via the docking of the synthesized compounds inside the active site of the protein, and the results were analyzed in terms of the best binding energy and appropriate docking pose. The top-ranked compounds were subjected to extensive MD simulation studies to understand the mode of interaction of the synthesized compounds and binding energies, as well as the contribution of individual residues towards binding affinities. Lower RMSD/RMSF values were observed for 2c and 3c, respectively, in the active site, confirming more stabilized, ligand-bound complexes when compared to the free state. An anisotropic network model was used to unravel the role of loop fluctuation in the context of ligand binding and the dynamics that are distinct to the bound and free states, supported by a 3D surface plot. An in vitro study revealed that 1c (IC50 = 1.26 µM) is far better than standard acarbose (2.15 µM), confirming the potential of this compound against the target protein. Given the appreciable potential of the candidate compounds against β-glucosidase, the synthesized compounds were further tested for their cytotoxic activity against hepatic carcinoma on HepG2 cancer cell lines. The cytotoxicity profile of the synthesized compounds was performed against HepG2 cancer cell lines. The resultant IC50 value (0.048 µM) for 3c is better than the standard (thalidomide: IC50 0.053 µM). The results promise the hypothesis that the synthesized compounds might become potential drug candidates, given the fact that the β-glucosidase inhibition of 1c is 40% better than the standard, whereas compound 3c holds more anti-tumor activity (greater than 9%) against the HepG2 cell line than the known drug.

Development of bioactive 2-substituted benzimidazole derivatives using an MnOx/HT nanocomposite catalyst

Benzimidazole is a vital moiety found in a wide range of naturally and pharmacologically active molecules. We prepared a proficient and facile manganese oxide-supported magnesium and aluminium-based nanocomposite catalytic framework using the deposition-precipitation method and characterised it with XRD, XPS, SEM, TEM, and TGA techniques. Following that, the catalyst was used in the green synthesis of highly functional 2-substituted benzimidazole derivatives in an ethanol-water solvent system at room temperature using various assorted benzaldehydes and o-phenylenediamine as substituents. The synthesised catalyst operates efficiently and is applicable to a wide range of electron-withdrawing and electron-donating substrates, resulting in good to excellent yields. The advantages of this process include the use of a greener solvent, high yield, high conversions, no use of additives or bases, a good TOF, and a shorter reaction time.

TiO2 nanoparticles decorated with Co-Schiff base-g-C3N4 as an efficient photocatalyst for one-pot visible light-assisted synthesis of benzimidazoles

In this study, a novel heterogeneous visible light-driven nanocatalyst was produced via the complexation of Co(ii) with g-C₃N₄-imine-functionalized TiO₂ nanoparticles. It was characterized using different techniques such as Fourier-transform infrared (FT-IR), energy-dispersive X-ray spectrum (EDS), inductively coupled plasma atomic emission spectroscopy (ICP-AES), thermogravimetric analysis (TGA), ultraviolet-visible diffuse reflectance spectroscopy (UV-vis DRS), X-ray diffraction (XRD), and scanning electron microscopy (SEM). The catalyst promoted several different transformations in a one-pot reaction sequence: aerobic photooxidation of benzylic alcohols to aldehydes and then the tandem synthesis of benzimidazoles through the dehydrogenative coupling of primary benzylic alcohols and aromatic diamines. The photocatalyst proved to be highly active, robust, selective, and recyclable under organic reaction conditions and provided affordable products with good to high yields. The results proposed that the improved photoactivity predominantly benefits from the synergistic effects of the heterojunction of Co-carbon nitride on TiO₂ nanoparticles. Moreover, this protocol provides standard conditions avoiding undesirable additives and limitations of oxidation methods, and may help to develop a new strategy for the development of photocatalysis based organic transformations.

The Co-g-C₃N₄-imine/TiO₂ nanohybrid promotes different transformations in a one-pot reaction sequence: aerobic photooxidation of benzylic alcohols to aldehydes, and then the tandem synthesis of benzimidazoles.

Recent Developments Towards Synthesis of (Het)arylbenzimidazoles

Benzimidazole is an important heterocycle that is widely researched and utilized by the pharmaceutical industry and is one of the five most commonly used five-membered aromatic heterocyclic compounds approved by the US Food and Drug Administration. In view of their wide-ranging bioactivities, systems containing benzimidazole as one of the moieties occupy a special place among other benzimidazole derivatives. Since 2010, many improved synthetic strategies have been developed for the construction of hetaryl- and arylbenzimidazole molecular scaffolds under environmentally benign conditions. This review emphasizes the recent trends and modifications frequently used in the synthesis of derivatives of benzimidazole such as the Phillips–Ladenburg and Weidenhagen reactions, as well as entirely new methods of synthesis, involving oxidative cyclization, cross-coupling, ring distortion strategy, and rearrangements carried out under environmentally benign conditions.

1 Introduction

2 From 1,2-Diaminobenzenes with Various One-Carbon Unit Suppliers

2.1 Phillips–Ladenburg Reaction

2.1.1 With (Het)arenecarboxylic Acids

2.2.2 With (Het)arenecarboxylic Acid Derivatives

2.2 Weidenhagen Reaction

2.2.1 With (Het)arenecarbaldehydes or (Het)aryl Methyl Ketones

2.2.2 With Primary Alcohols

2.2.3 With Primary Alkylamines

2.2.4 With 2-Methylazaarenes

2.2.5 With Other One-Carbon Fragment Suppliers

3 From 2-Haloacetanilides and Amines

4 From Amidines

5 From Tetrahydroquinazolines

6 Mamedov Rearrangement

7 Conclusions and Outlook